Cell type mediated resistance of vesicular stomatitis virus and Sendai virus to ribavirin.
Ribavirin (RBV) is a synthetic nucleoside analog with broad spectrum antiviral activity. Although RBV is approved for the treatment of hepatitis C virus, respiratory syncytial virus, and Lassa fever virus infections, its mechanism of action and therapeutic efficacy remains highly controversial. Rece...
Main Authors: | Nirav R Shah, Amanda Sunderland, Valery Z Grdzelishvili |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2010-06-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2889835?pdf=render |
Similar Items
-
Cellular proteins associated with the interior and exterior of vesicular stomatitis virus virions.
by: Megan Moerdyk-Schauwecker, et al.
Published: (2014-01-01) -
Acquired chemoresistance can lead to increased resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus
by: Dakota W. Goad, et al.
Published: (2022-03-01) -
Analysis of virion associated host proteins in vesicular stomatitis virus using a proteomics approach
by: Hwang Sun-Il, et al.
Published: (2009-10-01) -
Expanding the Spectrum of Pancreatic Cancers Responsive to Vesicular Stomatitis Virus-Based Oncolytic Virotherapy: Challenges and Solutions
by: Molly C. Holbrook, et al.
Published: (2021-03-01) -
MxA Mediates SUMO-Induced Resistance to Vesicular Stomatitis Virus.
by: Maarifi, G, et al.
Published: (2016)